Cannafen

**Cannafen** was a Senzer-developed inhaled cannabidiol product intended for relief of neuropathic pain, particularly neuropathic pain associated with cancer treatment. It used Senzer's breath-activated, non-combustion inhaler platform to deliver a defined dose of pharmaceutical cannabinoid aerosol to the lungs. Public reporting identified Cannafen specifically as a cannabidiol inhaler, but detailed formulation attributes, dose, clinical pharmacology, and product-specific molecular target data were not publicly disclosed. ([oindpnews.com](https://www.oindpnews.com/2020/03/senzer-obtains-ind-data-package-for-inhaled-dronabinol-from-insys-therapeutics/))

Brand names

Cannafen

Other names

Cannafen cannabidiol inhaler